Portfolio company
CellType
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops artificial intelligence agents and biological foundation models to simulate human biology for pharmaceutical and biotechnology drug discovery teams.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cellular Intelligence
This company develops artificial intelligence foundation models to predict cell signaling and design cell therapies for pharmaceutical companies and clinical researchers.
Deeplife
This company develops a cellular digital twin platform using artificial intelligence and multi-omics data to accelerate drug discovery for biotechnology and pharmaceutical researchers.
Techbio 2.0
This company develops induced pluripotent stem cell models and artificial intelligence platforms to provide predictive drug discovery data for pharmaceutical and biotechnology researchers.
Tahoe
This company develops artificial intelligence models and datasets of human cell responses to help biotechnology firms discover drugs and precision medicines.
Immunara
This company develops biological foundation models and artificial intelligence to map immune system interactions for pharmaceutical and biotechnology researchers.
CellRep
CellRep develops an artificial intelligence platform discovering small molecules that rejuvenate immune cells for developers of cell therapies and regenerative medicine.
Anto
This company develops foundation models to predict drug toxicity and efficacy by analysing gut microbiome data for pharmaceutical firms and drug developers.
Computational drug discovery platform
This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.
